Literature DB >> 16304192

Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.

Kathrin Heyn1, Antje Tredup, Stefanie Salvenmoser, Frank-Michael C Müller.   

Abstract

Effects of voriconazole combined with micafungin against 101 isolates of Candida spp. and 100 isolates of filamentous fungi have been evaluated by in vitro checkerboard analysis. The combination was indifferent for 97% of the Candida isolates and synergistic for 64% of the filamentous fungi (79% for Aspergillus fumigatus).

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16304192      PMCID： PMC1315951          DOI： 10.1128/AAC.49.12.5157-5159.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.

Authors:  F M Müller; M Weig; J Peter; T J Walsh
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

2.  Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Alia A Sarafandi; Amy M Kelaher; Caron A Lyman; Heather E Casler; Tin Sein; Andreas H Groll; John Bacher; Nilo A Avila; Thomas J Walsh
Journal:  J Infect Dis       Date:  2003-06-04       Impact factor: 5.226

3.  Synergy, antagonism, and what the chequerboard puts between them.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

4.  Colorimetric assay for antifungal susceptibility testing of Aspergillus species.

Authors:  J Meletiadis; J W Mouton; J F Meis; B A Bouman; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; S Nangia; J H Rex
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method.

Authors:  J Meletiadis; J F Meis; J W Mouton; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

7.  Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis.

Authors:  F M Müller; O Kurzai; J Hacker; M Frosch; F Mühlschlegel
Journal:  J Antimicrob Chemother       Date:  2001-11       Impact factor: 5.790

Review 8.  Voriconazole: therapeutic review of a new azole antifungal.

Authors:  Raoul Herbrecht
Journal:  Expert Rev Anti Infect Ther       Date:  2004-08       Impact factor: 5.091

9.  Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.

Authors:  P H Chandrasekar; J L Cutright; E K Manavathu
Journal:  Clin Microbiol Infect       Date:  2004-10       Impact factor: 8.067

10.  A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT).

Authors:  T Meshulam; S M Levitz; L Christin; R D Diamond
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226
View more
  27 in total

1.  Treatment options in emerging mold infections.

Authors:  Patricia Muñoz; Jesús Guinea; Emilio Bouza
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

Review 2.  Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

3.  Clinical and morphologic findings in disseminated Scedosporium apiospermum infections in immunocompromised patients.

Authors:  Molly M Campa-Thompson; James A West; Joseph M Guileyardo; Cedric W Spak; Louis M Sloan; Stacy G Beal
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-07

4.  Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.

Authors:  Jin Yu; Xiangdong Mu; Ruoyu Li
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

5.  A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates.

Authors:  Sherman Chu; Lisa Long; Rania Sherif; Thomas S McCormick; Katyna Borroto-Esoda; Stephen Barat; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

6.  Scedosporium apiospermum brain abscesses in an immunocompetent man with silicosis.

Authors:  Heather L Wilson; Karina J Kennedy
Journal:  Med Mycol Case Rep       Date:  2013-03-01

Review 7.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 8.  Impact of multidrug-resistant organisms on patients considered for lung transplantation.

Authors:  Shmuel Shoham; Pali D Shah
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

Review 9.  Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.

Authors:  Esther Benamu; Alexander Tin-Han Yu; Lijia Xie; Sebastian Fernandez-Pol; Anne Y Liu; Dora Y Ho
Journal:  Transpl Infect Dis       Date:  2017-12-21       Impact factor: 2.228

Review 10.  Voriconazole : a review of its use in the management of invasive fungal infections.

Authors:  Lesley J Scott; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.